Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine.
Peterson JT, Zareba AM, Fitz-Patrick D, Essink BJ, Scott DA, Swanson KA, Chelani D, Radley D, Cooper D, Jansen KU, Dormitzer PR, Gruber WC, Gurtman A.
J Infect Dis. 2022 Jun 15;225(12):2077-2086. doi: 10.1093/infdis/jiab505.
PMID:34637519
Pertussis: Common Questions and Answers.
Kline JM, Smith EA, Zavala A.
Am Fam Physician. 2021 Aug 1;104(2):186-192.
PMID:34383446
Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial.
Munoz FM, Bond NH, Maccato M, Pinell P, Hammill HA, Swamy GK, Walter EB, Jackson LA, Englund JA, Edwards MS, Healy CM, Petrie CR, Ferreira J, Goll JB, Baker CJ.
JAMA. 2014 May 7;311(17):1760-9. doi: 10.1001/jama.2014.3633.
PMID:24794369
Identification of Formaldehyde-Induced Modifications in Diphtheria Toxin.
Metz B, Michiels T, Uittenbogaard J, Danial M, Tilstra W, Meiring HD, Hennink WE, Crommelin DJA, Kersten GFA, Jiskoot W.
Safety and immunogenicity of conjugate vaccine for typhoid (Vi-DT): Finding from an observer-blind, active-controlled, randomized, non-inferiority, phase III clinical trial among healthy volunteers.
Tamrakar D, Poudel P, Thapa P, Singh S, Khadgi A, Thapa S, Tamrakar R, Shrestha A, Madhup S, Rai GK, Gupta BP, Saluja T, Sahastrabuddhe S, Shrestha R.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2301631. doi: 10.1080/21645515.2023.2301631. Epub 2024 Jan 8.
PMID:38189360
Clinical trials of the Haemophilus influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine.
Lepow M.
Pediatr Infect Dis J. 1987 Aug;6(8):804-7. doi: 10.1097/00006454-198708000-00042.
PMID:3313246
Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix): a review of its properties and use as a single-dose booster immunization.
Adverse events following quadrivalent meningococcal diphtheria toxoid conjugate vaccine (Menactra) reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2016.
Myers TR, McNeil MM, Ng CS, Li R, Marquez PL, Moro PL, Omer SB, Cano MV.